Antibody Response to Melanoma Helper-Peptide Vaccine Correlates With Survival

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p229
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Erratum To: Immunologic Hierarchy, Class II MHC Promiscuity, and Epitope Spreading of a Melanoma Helper Peptide Vaccine

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2014English

Function but Not Phenotype of Melanoma Peptide-Specific CD8+ T Cells Correlate With Survival in a Multiepitope Peptide Vaccine Trial (ECOG 1696)

International Journal of Cancer
Cancer ResearchOncology
2012English

Extended Dose Ipilimumab With a Peptide Vaccine: Immune Correlates Associated With Clinical Benefit in Patients With Resected High-Risk Stage IIIc/IV Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2012English

Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients With Different Solid Cancers

Cancer immunology research
Cancer ResearchImmunology
2015English

843 Immune Checkpoint Molecule PD-1H/VISTA Expression Correlates With Melanoma Survival

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

Journal of Immunology Research
MedicineAllergyImmunology
2016English

Immune Correlates of Melanoma Survival in Adoptive Cell Therapy

OncoImmunology
OncologyAllergyImmunology
2013English

MGMT Methylation Correlates With Melphalan Pelvic Perfusion Survival in Stage III Melanoma Patients

Melanoma Research
DermatologyCancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy